Please sign in to follow a disease.

Progressive astrocytoma, IDH-mutant, grade 4

Clinical trials for Progressive astrocytoma, IDH-mutant, grade 4 explained in plain language.

Never miss a new study

Get alerted when new Progressive astrocytoma, IDH-mutant, grade 4 trials appear

Sign up with your email to follow new studies for Progressive astrocytoma, IDH-mutant, grade 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental drug aims to boost immune attack on aggressive brain tumors

Disease control Recruiting now

This phase 2 trial tests a new drug called GI-102, alone or with the immunotherapy pembrolizumab, given before surgery to people with recurrent or progressive glioblastoma (a fast-growing brain cancer). The goal is to see if these drugs can increase cancer-fighting immune cells i…

Matched conditions: PROGRESSIVE ASTROCYTOMA, IDH-MUTANT, GRADE 4

Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

Progressive astrocytoma, IDH-mutant, grade 4

Get alerted when new Progressive astrocytoma, IDH-mutant, grade 4 trials appear

Experimental drug aims to boost immune attack on aggressive brain tumors